Johnson & Johnson MedTech unveiled its long-awaited Ottava surgical robot after winning FDA de novo authorization. It’s the ...
Medical Device Network on MSN
J&J MedTech jumps into surgical robot game as OTTAVA secures FDA nod
While not disclosing a specific launch timeframe, with de novo clearance in hand, J&J initially plans to launch Ottava with ...
Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the ...
J&J received FDA authorization for OTTAVA robotic surgical system, enabling commercial launch for surgery procedures in the US. Read more.
The advent of laparoscopic surgery has revolutionised splenic procedures by minimising trauma, reducing postoperative pain and shortening hospital stays while preserving immunological function.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results